UPDATE : Tuesday, July 23, 2019
상단여백
Oscotech wins exception policy for continued R&D for new drugs
The stock market regulator granted Oscotech to become the third KOSDAQ-list...
by Jeong Sae-im  |  2019-06-25 14:11
라인
Regulator OKs P3 trial for Eisai's Alzheimer treatment
The Ministry of Food and Drug Safety has approved the phase 3 clinical tria...
by Lee Han-soo  |  2019-06-25 14:09
라인
Novartis’ Cosentyx shows durable, comprehensive treatment for psoriatic disease
Novartis has released new data on five-year long-term immunogenicity and in...
by Lee Han-soo  |  2019-06-25 14:09
라인
Celltrion denies delay in local license application for HIV drug Temixys
The Ministry of Food and Drug Safety and Celltrion said rumors about the dr...
by Lee Hye-seon  |  2019-06-25 10:56
라인
'Elderly patients with atrial fibrillation have higher risk of dementia'
Researchers at Severance Hospital have found that elderly patients aged 60 ...
by Lee Han-soo  |  2019-06-24 15:50
라인
Latecomer experimental drug no better than Dupixent in trial
Pharmaceutical firms have strived to make latecomer drugs to beat Dupixent ...
by Kim Yun-mi  |  2019-06-24 15:49
라인
Daewoong wins new indications for Nabota
Daewoong Pharmaceutical's Nabota, its botulinum toxin (BTX) strain, has...
by Lee Han-soo  |  2019-06-24 14:47
라인
‘Expensive immunotherapies are not cure-all’
“Immunotherapies are increasingly drawing attention, but they cannot solve ...
by Park Gi-taek  |  2019-06-24 14:46
라인
Kang Stem Biotech completes P3 trials for stem cell-based atopy treatment
Kang Stem Biotech has completed the subject evaluation of phase 3 clinical ...
by Lee Han-soo  |  2019-06-24 12:19
라인
Anti-cancer Sutene could cause central nervous system abnormality in fetus
Pfizer Korea’s renal cancer treatments Sutene Cap. (ingredient: sunitinib m...
by Lee Hye-seon  |  2019-06-24 11:35
라인
KPBMA, KOTRA to support overseas expansion of pharmaceutical industry
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) a...
by Lee Han-soo  |  2019-06-24 11:34
라인
Boryung calls off ₩83-billion supply contract in Jordan
Boryung Pharmaceutical said that it has canceled its contract to supply 83 ...
by Lee Han-soo  |  2019-06-21 18:00
라인
‘Doctors, don’t be afraid to earn money’
“Doctors often ask me to help them make money out of a startup, but they ca...
by Kwak Sung-sun  |  2019-06-21 16:00
라인
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
The 2019 American Society of Clinical Oncology (ASCO) Annual Meeting was be...
by Lee Han-soo  |  2019-06-21 15:57
라인
MSD’s antibiotic Zerbaxa fails to get insurance coverage
MSD Korea’s antibiotic drug Zerbaxa Inj. failed to receive insurance covera...
by Kim Eun-young  |  2019-06-21 14:13
라인
‘Customized strategies needed for fast-changing Chinese drug regulation’
Foreign drugmakers need to make the most of China’s revised drug regulation...
by Jeong Sae-im  |  2019-06-21 14:12
라인
Researchers use platelet to diagnose cancer
Researchers at the Institute for Basic Science (IBS) have developed a techn...
by Lee Han-soo  |  2019-06-20 17:17
라인
Off-label use of Mabthera Inj. denied
The Health Insurance Review and Assessment Service (HIRA) said it has disap...
by Kim Yun-mi  |  2019-06-20 15:49
라인
AMC adopts new MRI-ultrasound fusion device to diagnose prostate cancer
Asan Medical Center said it has introduced Artemis, a machine that combines...
by Lee Han-soo  |  2019-06-20 15:43
라인
‘Korean cancer researchers have risen to world-class level’
The Korean Cancer Study Group (KCSG) said Korean institutions and researche...
by Kim Yun-mi  |  2019-06-20 15:04
여백
여백
여백
Back to Top